Home » Stocks » RACB

Research Alliance Corp. II (RACB)

Stock Price: $10.00 USD 0.00 (0.00%)
Updated Jun 15, 2021 4:00 PM EDT - Market open
Market Cap 167.10M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 16.71M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 15
Last Price $10.00
Previous Close $10.00
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 10.00 - 10.02
Day's Volume 45
52-Week Range 9.70 - 11.33


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

INDIANAPOLIS--(BUSINESS WIRE)--POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today th...

1 month ago - Business Wire

NEW YORK, March 27, 2021 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class ...

2 months ago - PRNewsWire

LAS VEGAS--(BUSINESS WIRE)--Research Alliance Corp. II (Nasdaq:RACB) (the “Company”) announced today that on March 22, 2021 it closed its initial public offering of 14,950,000 shares of Class A common s...

2 months ago - Business Wire

Research Alliance Corp. II (the “Company”) announced today that it priced its initial public offering of 13,000,000 shares of Class A common stock at $10.00 per share.

2 months ago - Business Wire

Research Alliance II, the second blank check company formed by RA Capital targeting the biotech industry, filed on Tuesday with the SEC to raise up to $130 million in an initial public offering.

3 months ago - NASDAQ

Research Alliance Corp. II has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC

About RACB

Research Alliance II is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare industry, with an emphasis on the biotechnology sector where our management has extensive investment ex... [Read more...]

Shell Companies
IPO Date
Mar 18, 2021
Peter Kolchinsky, Ph.D.
United States
Stock Exchange
Ticker Symbol
Full Company Profile